iShares Biotechnology ETF (NASDAQ:IBB) Shares Acquired by Main Street Financial Solutions LLC

Main Street Financial Solutions LLC increased its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 1.9% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 8,152 shares of the financial services provider’s stock after buying an additional 150 shares during the quarter. Main Street Financial Solutions LLC’s holdings in iShares Biotechnology ETF were worth $1,187,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in IBB. Blue Fin Capital Inc. increased its position in shares of iShares Biotechnology ETF by 0.7% during the second quarter. Blue Fin Capital Inc. now owns 10,516 shares of the financial services provider’s stock valued at $1,443,000 after acquiring an additional 74 shares during the last quarter. Security National Bank of SO Dak increased its holdings in iShares Biotechnology ETF by 0.7% in the 2nd quarter. Security National Bank of SO Dak now owns 10,461 shares of the financial services provider’s stock valued at $1,436,000 after purchasing an additional 75 shares during the last quarter. SPC Financial Inc. raised its position in iShares Biotechnology ETF by 2.4% in the third quarter. SPC Financial Inc. now owns 3,265 shares of the financial services provider’s stock valued at $475,000 after purchasing an additional 75 shares during the period. Werba Rubin Papier Wealth Management lifted its stake in iShares Biotechnology ETF by 2.7% during the third quarter. Werba Rubin Papier Wealth Management now owns 2,918 shares of the financial services provider’s stock worth $425,000 after purchasing an additional 76 shares in the last quarter. Finally, Perkins Coie Trust Co lifted its stake in iShares Biotechnology ETF by 0.3% during the second quarter. Perkins Coie Trust Co now owns 25,184 shares of the financial services provider’s stock worth $3,457,000 after purchasing an additional 83 shares in the last quarter. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Down 0.4 %

Shares of NASDAQ IBB opened at $143.80 on Thursday. iShares Biotechnology ETF has a twelve month low of $116.70 and a twelve month high of $150.57. The stock has a fifty day simple moving average of $144.78 and a 200-day simple moving average of $141.57.

iShares Biotechnology ETF Dividend Announcement

The company also recently announced a dividend, which was paid on Monday, September 30th. Shareholders of record on Wednesday, September 25th were given a $0.2005 dividend. The ex-dividend date was Wednesday, September 25th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.